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Vein diameter is the major predictor
of fistula maturation
Lannery S. Lauvao, MD, Daniel M. Ihnat, MD, Kaoru R. Goshima, MD, LeAnn Chavez, MD,
Angelika C. Gruessner, MS, PhD, and Joseph L. Mills Sr, MD, Tucson, Ariz
Objectives: Preoperative duplex ultrasound mapping of veins and arteries has been widely advocated to maximize the
creation of native arteriovenous fistula (AVF) for hemodialysis access, but reliable diameter criteria have not been
established. We sought to determine patient and anatomic variables predictive of fistula maturation in patients receiving
their initial permanent hemodialysis access.
Methods: All patients undergoing dialysis access creation from January 2003 to June 2007 were retrospectively reviewed.
We analyzed fistula type and functional maturation rates (Society for Vascular Surgery [SVS] reporting standards) based
on patient characteristics and findings on physical examination, preoperative vein mapping studies, or venography.
Maturation and patency rates were determined by Kaplan Meier analysis. The following factors were analyzed: age, race,
gender, body-mass index (BMI), fistula site, preoperative duplex vein diameter, diabetes, hyperlipidemia, HTN, prior
central catheter placement, HIV, and history of IV drug abuse.
Results: From January 2003 to June 2007, 298 vascular access procedures were performed. One hundred ninety-five
(65%) were initial hemodialysis access procedures, among which a native AVFwas created in 185 (95%); 158 patients with
posterior radiocephalic AVF (PRCAVF, n  24), wrist radiocephalic AVF (WRCAVF, n  72), or brachiocephalic AVF
(BCAVF, n 62) had adequate follow-up and were included in the analysis. PRCAVF, WRCAVF, and BCAVF had 54%,
66%, and 81%maturation rates, respectively. Both the type of fistula type (P .032) and vein size (P .002) significantly
affected maturation by univariate analysis. In contrast, by multivariate logistic regression analysis, vein diameter was the
sole independent predictor of fistula functional maturation (P  .002).
Conclusion: In this series of 158 patients undergoing initial hemodialysis access creation, native AVF creation was
performed in 95%. In contrast to previous reports, age, gender, diabetes, and BMI had no significant effect on functional
maturation. By multivariate logistic regression analysis, vein diameter was the sole independent predictor of functional
fistula maturation. (J Vasc Surg 2009;49:1499-504.)The U. S. Renal Data Systems (USRDS 2007) esti-
mated greater than 340,000 patients received hemodialysis
in 2005 and estimated an incidence of 317 patients per
million in that same year.1 The rate has continued to rise
2.8% since the year 2000. Native arteriovenous fistula
(AVF) is the preferred modality for hemodialysis access due
to lower rates of thrombosis, infection, and need for sec-
ondary interventions compared to grafts, as well as longer
survival and functional patency rates.2,3 The National Kid-
ney Foundation Kidney Disease Outcome Initiative (NKF
K/DOQI)4 implemented guidelines that resulted in the
Centers for Medicare andMedicaid Services (CMS) to help
sponsor the Fistula First Breakthrough Initiative (FFBI)
(also known as the National Vascular Access Improvement
Initiative) to increase native AVF rates to 66% by the year
2009.
The NKF K/DOQI recommends that the first choice
for native AVF is a wrist (radiocephalic) fistula, second is an
elbow (brachiocephalic) fistula, and third is either a trans-
posed brachial basilic vein fistula or a forearm arteriovenous
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doi:10.1016/j.jvs.2009.02.018graft. Despite the known higher incidence of failed matu-
ration for radiocephalic fistulas,5 the ease of placement and
the preservation of proximal vessels for future access out-
weigh such disadvantages. In addition to a complete history
and physical examination, routine preoperative duplex
ultrasonography (DUS) is also recommended by NKF
K/DOQI guidelines in all patients planned for hemodial-
ysis access. This has led to the increase of native AVF
placement and use.6-9 However, the role of duplex ultra-
sound in predicting maturation varies in the literature.
The purpose of this study is to carefully evaluate vari-
ables that affect initial autogenous hemodialysis accesses
maturation in the era of NKF K/DOQI. In addition, we
plan to evaluate the role of preoperative DUS vein sizes in
relation to fistula maturation. We suspect that patient fac-
tors such as age, gender, presence of diabetes, small vein
sizes, and radial-cephalic fistulas would have lower matura-
tion rates and would parallel similar failure rates in the
literature.10,11
METHODS
Patients referred for permanent hemodialysis access
from January 2003 to July 2007 had their records retro-
spectively reviewed. Approval from the University of Ari-
zona Institutional Review Board was obtained. The se-
lected populations were all direct referrals to a vascular
surgery practice at the University of Arizona Health Sci-
ences Center. All operations were performed at the Univer-
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nent hemodialysis access were included in the analysis. The
presence of a temporary dialysis catheter was not an exclu-
sion criterion. Information on patients with initial arterio-
venous fistula (AVF) or arteriovenous grafts (AVG) were
stored in a secure, Health Insurance Portability and
Accountability Act (HIPAA) compliant manner. Demo-
graphic data such as age, gender, race, and body-mass index
(BMI), in addition to comorbidities such as diabetes, hy-
perlipidemia, hypertension, tobacco use, human immuno-
deficiency virus (HIV) status, and history of intravenous
drug abuse, were documented. Etiology of renal failure was
noted along with the absence or presence of prior central
catheter access during fistula placement.
Arterial assessments included pulse examination, seg-
mental blood pressures in both upper extremities, and the
Allen test for continuity of the palmar arch. Venous assess-
ments include gross evaluation of the veins in the depen-
dent position with tourniquet enhancement in the upper
arm. Vein diameter was not estimated on physical exam.
Selection and placement of a permanent hemodialysis ac-
cess, based on physical examination alone, relies on the
assessment of the examining vascular surgeon.
Duplex ultrasonography (DUS) of arteries and veins
was an adjunct to physical examination in patients with
uncertainty to the quality and anatomy of the targeted
vessels. These noninvasive imaging were performed using a
5, 6, or 12 MHz scanning probe (Philips HDI 3000 and
5000 Systems, Amsterdam, The Netherlands) by registered
vascular technologists in an accredited vascular laboratory
(Intersocietal Commision for the Accreditation of Vascular
Laboratories). Vein assessments included diameter, com-
pressibility, depth, and continuity. These findings were
documented on a standardized form that has anatomical
illustrations to reflect findings at a specific location. Vein
sizes were recorded at the wrist, distal forearm, midfore-
arm, proximal forearm, antecubital fossa, distal upper arm,
mid upper arm, and proximal upper arm (performed both
with and without a forearm and arm tourniquet). The
mean, largest, and smallest vein diameter for a given ana-
tomic region (ie, forearm or upper arm) were recorded into
the database. Extremity arterial duplex assessment, if per-
formed, included the radial and brachial arterial size, pres-
ence or absence of calcification, segmental pressure, and
velocity waveforms. If physical examination and duplex
ultrasounography failed to demonstrate vessels necessary
for access, then venography was performed under protocols
developed by the division of interventional radiology.
The choice of operation for native AVF or AVG cre-
ation is based on the overall assessment of a board certified
vascular surgeon after evaluating all preoperative findings.
A uniform size threshold for acceptable vein diameter was
not used during the study period. All operations were
performed in the operating room under local, regional,
and/or general endotracheal anesthesia. All anastamoses
were performed using monofilament nonabsorbable
polypropylene running sutures. Patients were then seenroutinely 7 to 14 days postoperatively and then 4 to 6weeks
thereafter to assess for adequate maturation.
All data were entered into Excel spreadsheet (Mi-
crosoft, Redmond, Washington, USA). Data were entered
and reported using the Society for Vascular Surgery (SVS)
reporting standards for dealing with arteriovenous hemo-
dialysis access.12 The primary endpoint was fistulamatura-
tion and fistula functional maturation. Fistula maturation
is defined by the determination of both vascular surgeon
and nephrologist that an access is patent and ready for
cannulation based on adequacy of blood flow through the
fistula and the adequacy of vein dilation with respects to
length (10 cm segment), depth (6 mm), and diameter
(6 mm).4 This can be based on physical examination with
or without postoperative duplex ultrasound (DUS) evalu-
ation. Functional maturation is defined as successful can-
nulation of the fistula with the ability of the access to deliver
a flow rate of 350 to 400 ml/min and maintain dialysis for
4 hours or less.12 Primary fistula failure is defined as fistula
abandonment prior to cannulation regardless of patency
status.
Statistical analysis. Statistical analysis was performed
using SAS Statistics, version 9.2 (Cary, North Carolina,
USA). 2 analyses were used for independent variables and
value of P  .05 was considered statistically significant.
Logistical regression was used to calculate covariates of
interest coupled to fistula maturation. Time to maturation
and primary patency rates were evaluated with Life Table
estimates.
RESULTS
Patients. From January 2003 to July 2007, 298 per-
manent dialysis access procedures were performed at the
University Medical Center by four board certified vascular
surgeons. A total of 195 operations were first-time access.
Autogenous AV accesses were placed as first time perma-
nent access in 185 (95%) patients. The types of autogenous
AV access are listed in Table I with similar numbers for both
direct native wrist radiocephalic AVF (WRCAVF) and bra-
chiocephalic AVF (BCAVF). Of the primary autogenous
Table I. Distribution of hemodialysis access procedures
Number (%)
Total hemodialysis access 298
Prior access procedure 103
First access procedure 195 (100)
Autogenous AV access 185 (95)
PRCAVF (Snuff-box) 31 (16)
WRCAVF (Brescia-Cimino) 78 (40)
BCAVF (Kaufman) 72 (37)
BBAVF 4 (2)
Nonautogenous AV Graft 10 (5)
Lost to follow up 23 (12)
BBAVF, Brachial-basilic arteriovenous fistula; BCAVF, Brachial-cephalic
arteriovenous fistula; PRCAVF, Posterior radial-cephalic arteriovenous fis-
tula; WRCAVF, Wrist radial-cephalic arteriovenous fistula.AV fistulas, patients with brachial-basilic arteriovenous fis-
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placement were not included in analysis. Patients with
grafts were not included in further analyses. Mean follow
up was 15.2  1.5 months.
Demographics. Table II summarizes 158 total pa-
tients with primary autogenous permanent access with ad-
equate follow up. The mean age was 58 1.29 years, with
37% of patients older than 65 years of age. Male patients
compromise a majority of the study group. A total of 80
(51%) patients were already on dialysis with a central ve-
nous catheter. Diabetes was defined as adult onset, con-
trolled with diet or insulin, or juvenile onset as described by
SVS reporting standards. Similarly, hypertension was consid-
ered diastolic blood pressure greater than 90 mm Hg, or
blood pressure controlled with one or more anti-hypertensive
medications. Since 94% of patients had hypertension,
severe hypertension (hypertension requiring two or
more antihypertensive medications) was used a covariate
Table II. Demographic and clinical data for primary
hemodialysis access
Characteristic Number (%)
Total patients in analysis 158 (100)
Age (y)
Mean 58  1.29
Range 12-91
65 59 (37)
Gender
Male 99 (63)
Female 59 (37)
Ethnicity
Hispanic 71 (45)
Caucasian 69 (44)
African American 9 (6)
Native American 8 (5)
Comorbities
Diabetes mellitus 93 (59)
Hypertension 148 (94)
Tobacco use 26 (16)
Etiology of Renal Failure
Diabetes mellitus 76 (48)
Hypertension 31 (20)
PCKD 7 (4)
Glomerulonephritis 6 (4)
Other† 29 (18)
Unknown 9 (6)
Access based on physical examination only 61 (38)
Preoperative duplex ultrasound scanning 88 (56)
Preoperative venogram 11 (6)
Mean follow-up (days)
PRCAVF (n  24) 463  91.7
WRCAVF (n  72) 468  56.7
BCAVF (n  62) 476  50.0
Overall (n  158) 471  35.3
PCKD, Polycystic kidney disease.
†Other, acute tubular necrosis (ATN), congestive heart failure (CHF),
monoclonal gammopathy of undetermined significance (MGUS), systemic
lupus erythematosus (SLE), aminoglycoside toxicity, amyloidosis, cyclo-
sporine toxicity, focal segmental glomerulosclerosis, septicemia, multiple
myeloma, nephrectomy for malignancy, post renal obstruction, schistoso-
miasis, short bowel syndrome.of interest. Three patients had history of intravenous(IV) drug use (two patients report current use but on
exam could still receive an autogenous access.) No pa-
tient had a documented or reported history of human
immunodeficiency virus (HIV). The most common etiol-
ogy for renal failure was diabetes in 76 (48%) of patients.
DUS vein mapping was performed preoperatively in 88
patients; arterial DUS was performed preoperatively in only
26 patients. Preoperative venograms were ordered in 11
patients (6%). Of note, only three patients had a venogram
performed at the request of the vascular surgeon because of
inadequate veins on physical examination and DUS. The
majority of venograms (nine patients) were ordered and
performed prior to evaluation by a vascular surgeon.
Operative data and maturation outcome. Table III
describes the distribution of fistula types. Of 158 access
procedures, 47 fistulas were deemed not mature and were
either not used, or abandoned at last follow up (Table IV).
A total of 40 fistulas underwent revision, mostly for failure
to mature. Eight of the fistulas in which the vein failed to
dilate sufficiently for cannulation underwent revision in
attempt to salvage the fistula. The total number of fistulas
that matured was 111 (70%). Patients who had preopera-
tive DUS or venography had similar maturation rates com-
pared with those without preoperative studies, 71% (68/
96) versus 69% (43/62) (Table 5). Overall mean time to
fistula maturation was 82  1.29 days (n  111), and was
not significantly different when analyzed against fistula type
(P  .307). The total number of fistulas deemed “mature”
that actually become functionally mature at first time can-
nulation was 101 out of 111 (91%). Mean time from fistula
creation to first time cannulation was 147  19.6 days. Of
10 ‘mature’ fistulas that failed to achieve functional pa-
Table III. Patient population by procedure type and
maturation
Procedure
Number
(%)
Number
matured (%)
Mean days
to maturation
PRCAVF 24 (15) 13 (54%) 64.9  8.58
WRCAVF 72 (46) 48 (66%) 79.3  8.76
BCAVF 62 (39) 50 (81%) 89.9  14.18
P-value .032 .307
BCAVF, Brachial-cephalic arteriovenous fistula; PRCAVF, Posterior radial-
cephalic arteriovenous fistula; WRCAVF, Wrist radial-cephalic arterio-
venous fistula.
Table IV. Causes for primary fistula failure or
abandonment
Cause Number (%)
Thrombosis 17 (36)
Failure to mature 27 (58)
Immediate post procedure steal syndrome 1 (2)
Death 1 (2)
Renal transplant 1 (2)
Total 47 (100)tency, five were never used due to death, renal transplant,
al-ceph
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arm edema, two were too deep for cannulation and under-
went transposition, and one thrombosed during initial
dialysis access. Patients that had central venous catheters
had a shorter time to cannulation, 99  16.6 days com-
pared with patients without catheters 241 43.2 days (P
.004).
Age, race, gender, body-mass index (BMI), diabetes,
hypertension, tobacco use, time to referral, and prior dial-
ysis catheter placement had no effect on fistula maturation
by univariate or multivariate analysis. Both the type of
fistula type (P  .032) and vein size determined by DUS
(P  .002) significantly affected maturation by univariate
analysis. In contrast, vein size by DUS was the only signif-
icant variable on multivariate logistic regression analysis
(Table VI, P  .002). This finding was true when the
smallest vein size, mean vein size, and largest vein size for an
anatomic region were evaluated by DUS (size  4 mm),
but wasmost significant when the largest vein size in a given
anatomic region was used, opposed to using the smallest or
mean vein diameter.
DISCUSSION
Vascular surgeons and nephrologists recognize the sig-
nificant effect of the National Kidney Foundation
K/DOQI guidelines on vascular access in patients with
chronic kidney disease (CKD) stage 5. One of the notable
Table V. Maturation based on physical examination only,
venography
Variable Procedure Num
Physical exam only
PRCAVF
WRCAVF
BCAVF
Vein size  4.0 mm
PRCAVF
WRCAVF
BCAVF
Venogram
BCAVF, Brachial-cephalic arteriovenous fistula; PRCAVF, Posterior radi
fistula.
Table VI. Logistical regression analysis comparing
covariates with fistula maturation
Risk factor P-value
Odds
ratio
95% Confidence
interval
Age 65-99 years 0.672 0.79 0.263 2.366
Gender 0.254 0.52 0.166 1.605
Diabetes 0.482 1.56 0.447 5.501
Hypertension 0.749 1.36 0.210 8.762
Largest vein size on DUS 0.002 0.15 0.044 0.497
BCAVF 0.170 0.45 0.141 1.413
BCAVF, Brachial-cephalic arteriovenous fistula; DUS, Duplex ultrasonog-
raphy.successes of these guidelines is an increase in native fistulaplacement in many centers. K/DOQI guidelines are em-
braced by the Centers for Medicare and Medicaid Services
(CMS) and the Fistula First Breakthrough Initiative
(FFBI), which pushes for native arterial-venous fistula with
the goal creation rate of 65% by 2009.13 We report a 95%
native autogenous fistula placement in patients presenting
for initial permanent hemodialysis access, and a 70% matu-
ration rate.
Our previous experience was reported in 2003 by Patel
et al14 comparing several years of hemodialysis access oper-
ations with historical controls. Comparing current experi-
ence with the available reports shows that the mean ages
were similar (60.9 years vs. 58 years). The prevalence of
diabetes (62% vs. 59%) in the population groups is similar.
Hypertension, however, was found in 94% (148/158) of
patients in the current study compared with 51% (65/128)
as previously reported. This could be partly explained by
more aggressive control of hypertension. Interestingly, the
more noticeable differences observed were changes in re-
gional demographics in patients with CKD. More men had
first time access compared to our previous report (63% vs.
45%). Hispanic patients represented an increase in hemo-
dialysis access placement to 45% (71/158) from 38% (49/
128). Native Americans rates remain relatively unchanged
with 5% (8/158) versus 3% (4/128). Patel et al had a mean
maturation rate of 70 days from fistula creation to cannu-
lation. Currently, our rate from creation to cannulation
(functional maturity) was 147 days. This is contrasted to
results from the Dialysis Outcomes and Practice Patterns
Study (DOPPS) with a reported mean cannulation time of
98 days in the United States.15 It could be inferred that this
difference is due to the success of earlier referral for fistula
placement and/or aggressive preservation of residual kid-
ney function as encouraged by K/DQOI guidelines. Our
data showed that patients with central venous catheters had
a significantly shorter time to cannulation, than patients
without central venous catheters. Further studies are
needed to elucidate factors leading to such an interesting
observation.
A functionally mature AV fistula is clearly defined, and
widely accepted as the primary goal, but there is no con-
perative duplex ultrasonographic vein size, and
f patients Maturation (%) P-value
1 42 (70) 0.760
9 11 (57) 0.474
0 22 (73) 0.277
2 9 (75) 0.678
8 45 (94) 0.0002
2 2 0.135
8 15 0.341
8 28 0.005
1 7 (70) 0.618
alic arteriovenous fistula; WRCAVF, Wrist radial-cephalic arteriovenouspreo
ber o
6
1
3
1
4
1
2
1sensus in defining fistula maturation. Dember et al16 iden-
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for the Dialysis Access Consortium, as fistula suitability
with two needles to maintain an optimal dialysis flow rates
of 300mL/min during eight of 12 dialysis sessions. NKF
K/DOQI glossary has fistula maturation as “the process by
which a fistula becomes suitable for cannulation” and fo-
cuses on the Rules of Sixes: blood flow greater than 600
mL/min; a diameter greater than 0.6 cm; and a depth of
approximately 0.6 cm. SVS reporting standards for hemo-
dialysis access do not define fistula maturation, but rather
define AV access as “patency” and “functional.” Functional
patency is defined as is the ability of a hemodialysis access to
deliver a flow rate of 350 to 400 mL/min without access
recirculation to maintain a treatment time of less than four
hours.12 We defined fistula maturation as time from access
creation to a time an assessment by a vascular surgeon and
nephrologist determine a fistula can be cannulated. We
report 91% (101/111) of patients we deemed mature by
physical examination and post placement imaging, were
cannulated successfully (by SVS criteria). K/DOQI recom-
mends that a fistula should be placed at least six months
before initiation of hemodialysis. We predict that to meet
these guidelines, more fistulas will be created earlier, and
potentially will not be utilized for some generous period of
time. These should be excluded from functional patency
calculations.
It is endorsed by K/DOQI that preoperative DUS has
increased fistula placement rates.6-9 In our report, we found
no improvement in maturation rates when DUS was uti-
lized; we placed 38% native fistulas based on physical exam-
ination alone with a maturation rate of 69% compared with
71% in patients with preoperative studies. There are no
prospective randomized trials comparing physical examina-
tions alone to preoperative DUS in planning fistula place-
ment. Silva et al9 had minimum of 2.5 mm for vein size as
predictable for fistula success. In our current study, we
found that only a size  4 mm significantly predicted
maturation. Optimal preoperative vein size by DUS for
fistula creation has not been validated to prospective ran-
domized trials. Reporting standards for vein mapping (eg,
using smallest, largest, or mean vein diameter in a given
anatomic area), have not been established. Peterson et al17
recently noted that despite routine use of DUS vein map-
ping, disparities in maturation still existed. The authors
noted that female gender, age 65 years, and forearm
fistulas were predictive of fistula failure. Similarly, the same
institution reported earlier that female gender was predic-
tive of fistula failure.18 We, however, did not observe
female gender as a predictive variable to fistula failure. We
also did not find age as a variable predictive of maturation
failure and agree with Weale et al19 that age should not be
used solely to select type of fistula to be placed.
Vein size logically seems to be a major predictor of
fistula maturation if we solely base functional maturity on
flow. As Pouseuille’s law dictates, flow (Q) is proportional
to the product of change in pressure gradient (P) and the
fourth power of the vessel radius (r) divided by the viscosity
() of blood (Q  P 	 r4/). Larger veins (radius) meanlarger flow. However, such a simplistic view does not take
into account the arterial factors and normal pulsatile blood
flow. Furthermore, venous compliance after fistula creation
needs to be considered. As Corpataux et al20 found in
WRCAVF, vein luminal size can increase by 86% in one
week. However, distensibility (compliance) and not size
was reported by van der Linden et al to be predictive of
fistula maturation.21 Studies are still mandated to eluci-
date specific vein characteristics, (early post-operative
flow, vein size, or compliance) to increase fistula suitabil-
ity for dialysis.
We acknowledge that our study has a number of limi-
tations. This is a retrospective review that relies on available
patient information and it is vulnerable to availability and
accuracy. It exposes the limitation and inadequate follow
up in patients we place on permanent dialysis access. Our
group size is limited and only patients with adequate follow
up were included in the analysis. Furthermore, our defini-
tion of fistula maturation is limited on our clinical assess-
ment after fistula placement.
Our group remains aggressive in attempting to place
fistulas in all suitable patients. We do not have a current
minimal threshold vein size, but continue to use a combi-
nation of preoperative DUS vein mapping and physical
exam, and we are now looking more consistently at the
arteries. In the current study, we had eight patients with the
smallest vein diameter on DUS between 1.5 and 2 mm that
went on to mature their fistulas, and three that did not, so
we believe that surgeon’s judgment remains extremely
important. We continue to follow the NKF K/DOQI
recommendations and start as distally as possible, especially
in younger patients. For patients older than 75, we are
more reluctant to perform radiocephalic AVF at the wrist.
CONCLUSIONS
Our experience shows that vein size is the major
predictor for a successful fistula. Contrary to previous
reports, we did not show any difference in maturation
with other patient variables. While there is an increase in
fistula placement using DUS, studies are still mandated
to develop an optimal vein mapping protocol to predict
vein factors that affect maturation rates, including size
criteria.
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